MYRA SIKWATA: Open Payments
NPI 1083111777 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,329 in 107 payments from 14 companies in 2025. Trend: 2023 $41,386 · 2024 $58,180 · 2025 $30,329
Speaker / faculty: $16,250Travel & lodging: $10,214Food & beverage: $3,853Education: $12
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 56 | $28,493 |
| AstraZeneca Pharmaceuticals LP | 9 | $396 |
| ABBVIE INC. | 8 | $319 |
| Gilead Sciences, Inc. | 6 | $274 |
| Novo Nordisk Inc | 5 | $201 |
| Exact Sciences Corporation | 4 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $148 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Abbott Laboratories | 3 | $65 |
| Almatica Pharma LLC | 2 | $43 |
Products named: APRETUDE, BREZTRI, QULIPTA, Kerendia, Wegovy, The Cologuard Plus Collection Kit, REXULTI, FARXIGA.
Industry payments across IL — which companies pay providers there.
